 It's the first vaccine to have a 75% success rate, says the BBC's Dominic Hughes. This new vaccine is the second of its kind to target malaria, which claims the lives of around half a million people every year. But at just around $4 per dose, this jab costs less than half of the original, making it much more affordable in low-income countries.